Abstract:The role of different substituents in position 2 of 6,6‐diphenyl‐1,4‐dioxane muscarinic receptor ligands in the affinity for the five muscarinic acetylcholine receptor (mAChR) subtypes was studied. The tertiary amine 9 and its eutomer (S)‐(–)‐9 showed picomolar affinity and biphasic curves for all mAChRs. A new series of muscarinic acetylcholine receptor (mAChR) ligands obtained by inserting different substituents in position 2 of the potent 6,6‐diphenyl‐1,4‐dioxane antagonists 4 and 5 was designed and synthesized to investigate the influence of steric bulk on the mAChR affinity. Specifically, the insertion of a 2‐methyl group, affording compounds 6 and 9, resulted as the most favorable modification in terms of affinity for all muscarinic subtypes. As supported by computational studies performed on the hM1 receptor, this substituent may contribute to stabilize the ligand within the binding site by favoring the formation of stable interactions between the cationic head of the ligand and the residue D105. The increase of steric bulk, obtained by replacing the methyl group with an ethyl (7 and 10) and especially a phenyl substituent (8 and 11), caused a marked decrease of mAChR affinity, demonstrating the crucial role played by the steric bulk of the 2‐substituent in the mAChR interaction. The most intriguing result was obtained with the tertiary amine 9, which, surprisingly, showed two different pKi values for all mAChRs, with preferential subpicomolar affinities for the M1, M3, and M4 subtypes. Interestingly, biphasic curves were also observed with both the eutomer (S)‐(–)‐9 and the distomer (R)‐( + )‐9.

Recent Progress in Selective Muscarinic Agonists

Muscarinic Receptors and Related Selective Drugs: Research Advances

Design, Synthesis, And Sar Studies Of Heteroarylpyrimidines And Heteroaryltriazines As Cb2r Ligands

The Effect of Absolute Configuration on Activity, Subtype Selectivity (M3/M2) of 3Α-Acyloxy-6β-acetoxyltropane Derivatives As Muscarinic M3 Receptor Antagonists

New potent muscarinic receptor ligands bearing the 1,4‐dioxane nucleus: Investigation on the nature of the substituent in position 2

The optimization of a novel selective antagonist for human M<sub>2</sub> muscarinic acetylcholine receptor

Design and synthesis of 2-(2,2-diarylethyl)-cyclamine derivatives as M3 receptor antagonists and functional evaluation on COPD

Structure Modification and Structure-Activity Relationship of Anisodamine

( S )- N -Benzyl-1-phenyl-3,4-dihydroisoqunoline-2(1 H )-carboxamide Derivatives, Multi-Target Inhibitors of Monoamine Oxidase and Cholinesterase: Design, Synthesis, and Biological Activity.

Discovery of Fused Heterocyclic Carboxamide Derivatives As Novel Α7-Nachr Agonists: Synthesis, Preliminary SAR and Biological Evaluation.

Design, Synthesis, and Biological Evaluation of 4,4’-Difluorobenzhydrol Carbamates as Selective M1 Antagonists

Structure-guided development of selective M3 muscarinic acetylcholine receptor antagonists.

Agonist-selective activation of individual G-proteins by muscarinic receptors

Recent progress in the development of β2 adrenergic receptor agonists: a patent review (2015-2020)

Muscarinic Acetylcholine Receptor Modulators Derived from Natural Toxins and Diverse Interaction Modes

Structural Optimizations and Bioevaluation of N-H Aporphine Analogues As Gq-biased and Selective Serotonin 5-HT2C Receptor Agonists.

Discovery of Biphenyl Piperazines As Novel and Long Acting Muscarinic Acetylcholine Receptor Antagonists

Synthesis and Biological Activity of Tropane Derivatives

Activity and QSAR Study of Baogongteng A and Its Derivatives As Muscarinic Agonists

Synthesis and Vascular Relaxing Activity of New Arecoline Analogues Containing 1,2,4-Triazole Sulfanylether

Muscarine, Imidazole, Oxazole and Thiazole Alkaloids